Release Date: 20/03/17 17:58 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 89.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%